Detroit, MICHIGAN3 Active Studies

Amyloidosis Clinical Trials in Detroit, MICHIGAN

Find 3 actively recruiting amyloidosis clinical trials in Detroit, MICHIGAN. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
351
Enrolling

Recruiting Amyloidosis Studies in Detroit

About Amyloidosis Clinical Trials in Detroit

Amyloidosis is a group of diseases in which abnormal proteins (amyloids) build up in organs and tissues, impairing their function. Types include AL, AA, and ATTR amyloidosis. Treatment depends on the type and may include chemotherapy, organ transplant, or targeted therapies.

There are currently 3 amyloidosis clinical trials recruiting participants in Detroit, MICHIGAN. These studies are seeking a combined 351 participants. Research is being sponsored by Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Inc., Nexcella Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Amyloidosis Clinical Trials in Detroit — FAQ

Are there amyloidosis clinical trials in Detroit?

Yes, there are 3 amyloidosis clinical trials currently recruiting in Detroit, MICHIGAN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What amyloidosis treatments are being tested?

The 3 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for amyloidosis.

Data updated March 2, 2026 from ClinicalTrials.gov